Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4L pseudogene 2 (MTND4LP2) is a mitochondrial pseudogene and not a functional protein-coding gene. It is annotated by the HUGO Gene Nomenclature Committee (HGNC) as a pseudogene[9]. Unlike the functional MT-ND4L gene, which encodes a subunit of NADH:ubiquinone oxidoreductase (Complex I) and plays an essential role in mitochondrial respiration, this pseudogene does not encode an active protein product, has no known biological function, and is not implicated in human disease processes or considered as a therapeutic target[9]. No disease roles, molecular targets, or drug interactions are reported for this pseudogene. Note: - MT-ND4L (without "pseudogene 2") refers to a functional mitochondrial gene essential in oxidative phosphorylation and is associated with diseases such as Leber hereditary optic neuropathy[1][4][6], but MT-ND4L pseudogene 2 is not functionally analogous. - The presence of “pseudogene” in the name and its registry in nomenclature databases as a pseudogene means it does not meet criteria for a therapeutic target or functional molecule in drug discovery or clinical settings[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4L pseudogene 2 (MTND4LP2).